Estados Unidos · Bolsa y Finanzas · Morningstar

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

Publicado por Morningstar · Estados Unidos hace 17 h

NORTH CHICAGO, Ill., Oct. 11, 2026 /PRNewswire/ -- AbbVie today announced the presentation of 22 scientific abstracts from its market-leading inflammatory bowel disease (IBD)…

Leer el artículo completo en Morningstar Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.morningstar.com)

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

También te puede interesar

The investor’s guide to TechCrunch Disrupt 2026: Everything you need to know

Starknet coin surges as developer weighs Ethereum split over quantum security

For the first time ever, 10-year bond yields track diesel prices more closely than crude, and Trump’s fuel deal with Putin may be too little too late

Tokenized Stocks Show Real Demand But Remain Volatile and Illiquid, IMF Finds

From BJ’s to Lululemon, retailers are trimming assortments to boost business

Saylor teases Strategy Bitcoin buying after ending September with STRC buybacks

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

Compartir

También te puede interesar

The investor’s guide to TechCrunch Disrupt 2026: Everything you need to know

Starknet coin surges as developer weighs Ethereum split over quantum security

For the first time ever, 10-year bond yields track diesel prices more closely than crude, and Trump’s fuel deal with Putin may be too little too late

Tokenized Stocks Show Real Demand But Remain Volatile and Illiquid, IMF Finds

From BJ’s to Lululemon, retailers are trimming assortments to boost business

Saylor teases Strategy Bitcoin buying after ending September with STRC buybacks